Distinct Regulatory and Effector T Cell Metabolic Demands during Graft-Versus-Host Disease

由 Hippen, K.L., Aguilar, E.G., Rhee, S.Y., Bolivar-Wagers, S., Blazar, B.R.
發表在 Trends Immunol (2019)

Superiority of Rapamycin over Tacrolimus in Preserving Non-human Primate Treg Half-life and Phenotype After Adoptive Transfer

由 Singh, K, Stempora, L, R. Donald, Harvey, Kirk, AD, Larsen, CP, Blazar, BR, Kean, LS
發表在 Am J Transplant (2014)

Regulatory T cells Exhibit Decreased Proliferation but Enhanced Suppression After Pulsing with Sirolimus

由 Singh, K., Kozyr, N., Stempora, L., Kirk, A.D., Larsen, C.P., Blazar, B.R., Kean, L.S.
出版 2012

Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation

由 He, F, Verneris, MR, Cooley, S, Blazar, BR, MacMillan, ML, Newell, LF, Panoskaltsis-Mortari, A, DeFor, T, Weisdorf, DJ, Holtan, SG
發表在 Bone Marrow Transplant (2016)

Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease

由 Hippen, K.L., Merkel, S.C., Schirm, D.K., Nelson, C., Tennis, N.C., Riley, J.L., June, C.H., Miller, J.S., Wagner, J.E., Blazar, B.R.
出版 2011

In vitro induction of human regulatory T-cells (iTregs) using conditions of low tryptophan plus kynurenines

由 Hippen, K.L., O’Connor, R.S., Lemire, A.M., Saha, A., Hanse, E.A., Tennis, N.C., Merkel, S.C., Kelekar, A, Riley, J.L., Levine, B.L., June, C.H., Kean, L.S., MacMillan, M.L., Miller, J.S., Wagner, J.E., Munn, D.H., Blazar, B.R.
發表在 Am J Transplant (2017)